6.7563
Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten
CNS Pharmaceuticals shares dip after CEO departure announcement - MSN
CNS Pharmaceuticals appoints Rami Levin as CEO effective Jan 1, 2026 - marketscreener.com
CNS Pharmaceuticals stock falls after CEO steps down - Investing.com India
CNS Pharmaceuticals appoints Rami Levin as CEO, John Climaco resigns - Investing.com
CNS Pharmaceuticals Announces New CEO Appointment - TipRanks
CNS Pharmaceuticals (CNSP) Appoints New CEO - GuruFocus
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco - Investing.com India
CNS Pharmaceuticals Announces CEO Transition - Waco Tribune-Herald
Brain cancer drug developer taps new CEO with global track record - Stock Titan
Cycle buying Applied Therapeutics to develop CNS drugs - BioWorld MedTech
CNS Pharmaceuticals (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast - Digital Journal
CNS Pharmaceuticals CEO Outlines Strategy to Target Glioblastoma by Overcoming Blood-Brain Barrier - citybuzz
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics ... - Enidnews.com
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference - GlobeNewswire
Will CNS Pharmaceuticals Inc. stock gain from lower inflationGold Moves & High Accuracy Trade Alerts - Newser
CNS Pharma (CNSP) Stock Analysis Report | Financials & Insights - Benzinga
Acumen and JCR Advance Next-Generation CNS Therapeutics with EBD™ Technology - citybiz
CNS Pharmaceuticals, Inc. (CNSP) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Alector to Participate in the Bank of America CNS Therapeutics Conference - Yahoo Finance
What analysts say about CNS Pharmaceuticals Inc stockGrowth vs. Value Investing & High Profit Investment Ideas - earlytimes.in
Where Analysts See Bemco Hydraulics Limited Stock by YearEndRisk-Reward Ratio Analysis & Free Rapid Return Acceleration - earlytimes.in
Bank of America CNS Therapeutics Virtual Conference - marketscreener.com
CNS Pharmaceuticals, Inc.Common Stock (NQ: CNSP - Markets Financial Content
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - The Manila Times
Catalyst Pharmaceuticals (Nasdaq: CPRX) at BofA CNS Therapeutics Conference Dec. 8 - Stock Titan
CNS Pharmaceuticals Increases Authorized Shares for Growth - The Globe and Mail
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting - Investing.com Australia
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting By Investing.com - Investing.com South Africa
CNSP shareholders approve major share increase and equity plan changes - Stock Titan
How strong is CNS Pharmaceuticals Inc. stock revenue growthWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
How CNS Pharmaceuticals Inc. stock responds to policy changesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Can CNS Pharmaceuticals Inc. stock outperform in 2025 bull marketAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock gaining market shareJuly 2025 Review & AI Optimized Trade Strategies - newser.com
Is CNS Pharmaceuticals Inc. stock reversal real or fakeJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
[Form 4] CNS Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Trend analysis for CNS Pharmaceuticals Inc. this weekJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com
Will CNS Pharmaceuticals Inc. stock deliver better than expected guidance2025 AllTime Highs & Real-Time Chart Breakout Alerts - newser.com
CNS Pharmaceuticals Reports Financial Gains Amid Ongoing R&D - MSN
Full technical analysis of CNS Pharmaceuticals Inc. stockJuly 2025 Trends & Precise Trade Entry Recommendations - newser.com
Will CNS Pharmaceuticals Inc. stock gain from government policiesJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Why CNS Pharmaceuticals Inc. stock remains resilientMarket Growth Summary & Verified Entry Point Detection - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):